COVID-19

delete sermo.jpg

https://www.elitetrader.com/et/threads/covid-19-real-time-barometer-study-whats-up-doc.343101/
 
Remdivir showing promise for the sickest patients. Early and incomplete but it’s hard to get past the significant percentage of extubated patients. Also, this study was done by reputable hospitals and doctors.

https://www.nejm.org/doi/pdf/10.1056/NEJMoa2007016?articleTools=true&mod=article_inline

It should be noted that Remdivir is the primary medication being used in South Korea which has had good success in their response to COVID-19 (due to a number of factors including proper tracing and testing). The results of attempting to use hydroxychloroquine in South Korea showed no real positive results.
 
https://www.guggenheiminvestments.c...-outlook/the-emerging-emerging-markets-crisis

The Emerging Emerging-Markets Crisis
Global capital markets are not pricing in the growing likelihood of rising EM corporate defaults.

The emerging markets soon will be hit very hard by the global pandemic. The pandemic will be followed by goods and food shortages, and social unrest. Before the virus hit them directly, EM countries had already been adversely affected by falling commodity prices and the economic impact of the shutdown in China and other parts of the developed world. Most EM countries have very weak healthcare systems, nowhere near enough hospital beds and respirators, crowded cities and slums, and large numbers of workers in the economy who are paid daily wages or work in the informal economy and can’t work remotely. For many EM countries, this pandemic will quickly escalate from a health crisis to a humanitarian crisis, and ultimately to a solvency crisis. Political stability will be the last domino to fall.
 
Back
Top